skip to Main Content

August 3, 2020
Letter to Sanofi CEO Calling for Patent Withdrawals on Critical TB Drugs
Letter / Comment
TAG and our French partners OTMeds (Observatoire de la transparence dans les politiques du médicaments) sent a letter to Sanofi CEO Paul Hudson calling on the company to reverse its efforts to patent two obvious combinations of two critical drugs to prevent tuberculosis: rifapentine and isoniazid.

July 28, 2020
An Activist’s Guide to Treatment for Drug-Resistant Tuberculosis
The 2020 updates to the World Health Organization (WHO) guidelines shifted the global standard of care for drug-resistant TB in a number of important ways. Our publication, An Activist’s Guide to Treatment for Drug-Resistant Tuberculosis, details these shifts and other important information about the new global standard of care for…

July 28, 2020
An Activist’s Guide to Tuberculosis Diagnostic Tools
Our publication, An Activist’s Guide to Tuberculosis Diagnostic Tools, details the latest WHO recommendations, the array of available TB diagnostic tools, and how these tools should be optimally used in country programs, including to support TB screening and diagnosis among special populations such as children, people with extrapulmonary TB, and…

July 21, 2020
In Memoriam – The Honorable John Lewis
Statement / Press
Treatment Action Group (TAG) honors the titanic historic legacy and mourns the recent death of the Honorable John Lewis, U.S. Representative from the 5th Congressional district in Georgia and legendary civil rights leader.

July 7, 2020
Global Health and Human Rights Organizations Say U.S. Withdrawal from WHO Is Reckless Act That Could Delay Americans’ Access to COVID-19 Solutions and Prolong Global Pandemic
Statement / Press
AVAC, Health GAP and the Treatment Action Group (TAG) strongly condemn the Trump Administration’s withdrawal from the World Health Organization (WHO).

July 6, 2020
Treatment Action Group Statement on Bedaquiline Unaffordability
Statement / Press
Treatment Action Group welcomes the Global Drug Facility / Stop TB Partnership’s negotiation of what amounts to a 32% savings on bedaquiline, the backbone of improved, all-oral regimens for treating drug-resistant TB.

July 2, 2020
2020 Pipeline Report
Pipeline Report
Pipeline Report provides an overview of research and provides an overview of research and development of innovations for diagnosing, preventing, treating, and curing HIV, hepatitis C virus (HCV), and tuberculosis (TB).

June 23, 2020
Letter to United Nations High Commissioner for Human Rights Regarding COVID-19 and the Right to Science
Letter / Comment
TAG sent this letter calling on the Office of the High Commissioner for Human Rights (OHCHR) and the Human Rights Council (HRC) to explicitly acknowledge the human rights dimensions of science and reaffirm the right of everyone to participate in and enjoy the benefits of scientific progress and its applications…

June 18, 2020
Treatment Action Group Commemorates Juneteenth through Solidarity Actions, Reflection, and Transparency
Statement / Press
Tomorrow, Treatment Action Group (TAG) will be observing and honoring Juneteenth—a commemoration of the end of slavery in the United States—through a day of solidarity, actions, and reflection.

June 12, 2020
Podcast with Dr. Madhukar Pai: TB Diagnostics Advocacy in the Context of COVID-19
On this podcast, Dr. Madhukar Pai describes the ways that the COVID-19 pandemic has delayed and limited access to TB diagnostic testing, and how all stakeholders must step-up efforts to mitigate these impacts and ensure that TB diagnostic testing is not abandoned in the response to COVID-19.

Back To Top